Two areas of preventive screening are specifically relevant to female physiology, and general checkups don't always prompt on them: bone density and cardiovascular risk.
Bone Density
Declining oestrogen around menopause accelerates bone loss, making osteoporosis screening a genuinely female-specific preventive priority. Current national screening guidance recommends bone density testing (typically a DEXA scan) for all women 65 and older, and for postmenopausal women younger than 65 who have elevated fracture risk based on a clinical risk assessment[12]. This is a straightforward, low-burden test that catches a genuinely modifiable risk — early bone loss responds to intervention (weight-bearing exercise, adequate calcium and vitamin D, and medication where appropriate) far more effectively than bone loss caught only after a fracture has already occurred.
Cardiovascular Risk Shifts Around Menopause
Oestrogen has a protective effect on cardiovascular risk factors before menopause; that protection diminishes as oestrogen declines, which is part of why cardiovascular risk in women tends to rise more steeply after menopause than before it. Menopause is a reasonable trigger to revisit blood pressure, cholesterol, and metabolic screening with fresh attention, not a one-time checklist item to complete once and forget — the full screening framework is covered in the Heart & Metabolic Health guide.
The Screening Checklist
| Screening | When | Why |
|---|---|---|
| Bone density (DEXA) | 65+, or earlier with risk factors | Oestrogen decline accelerates bone loss; early intervention is far more effective than post-fracture treatment |
| Cardiovascular risk panel | Revisit around menopause | Cardiovascular risk rises more steeply after menopause as oestrogen's protective effect diminishes |
| Cervical screening | Per current national guidelines — ask your doctor for the current interval | Guidelines have changed over time; confirm you're on the current recommended schedule rather than an outdated one |